J&J | Netto Inntekt



Net Income Endring Dato
AbbVie USD 1.29B 1.31B 2025-03
Abbott USD 1.33B 7.9B 2025-03
Amgen USD 627M 2.2B 2024-12
AstraZeneca USD 2.92B 1.42B 2025-03
Baxter International USD -512000000 652M 2024-12
Bayer EUR -335000000 3.85B 2024-12
Becton, Dickinson and Co. USD 303M 97M 2024-12
Biogen USD 266.7M 121.8M 2024-12
Boston Scientific USD 674M 108M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
CONMED USD 6.04M 27.72M 2025-03
Cooper Companies USD 104.3M 13.2M 2025-01
Dexcom USD 151.7M 17.1M 2024-12
Edwards Lifesciences USD 358M 27.6M 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Globus Medical USD 26.5M 25.33M 2024-12
Hologic USD 201M 22.4M 2024-12
Indivior 48M 11M 2025-03
Insulet USD 100.7M 23.2M 2024-12
Integra LifeSciences USD 19.43M 30.13M 2024-12
Intuitive Surgical USD 698.4M 12.7M 2025-03
J&J USD 11B 7.57B 2025-03
Medtronic USD 1.29B 25M 2025-01
Merck USD 5.08B 1.34B 2025-03
Merit Medical Systems USD 30.15M 2.2M 2025-03
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
Stryker USD 546M 288M 2024-12
Tandem Diabetes Care USD -130556000 131.31M 2025-03
Teva Pharmaceutical Industries USD -217000000 220M 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12
Zimmer Biomet Holdings USD 239.4M 9.6M 2024-12
Zoetis USD 581M 101M 2024-12



J&J Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.